First Cited
Last Cited

Articles citing This Document (Page 1 of 9)

Targeting androgen receptor for prostate cancer therapy: From small molecules to PROTACs2022
Systemic inflammatory biomarkers as predictive and prognostic factors in men with metastatic castration-refractory prostate cancer treated with docetaxel therapy: a comprehensive analysis in a German real-world cohort
Metastatic Prostate Adenocarcinoma Presenting as Acute Quadriplegia: A Case Report and Racial Disparity Analysis2022
Role of baseline 68Ga-PSMA PET/CT-derived whole-body volumetric parameters in predicting survival outcomes of metastatic castration-resistant prostate cancer patients receiving first-line treatment
Disease Burden of Prostate Cancer from 2014 to 2019: Estimation from the Global Burden of Disease Study 2019 and Medical Expenditure Panel Survey.
Concordance between influential adverse treatment outcomes and localized prostate cancer treatment decisions2022
Systemic therapy response evaluation in prostate carcinoma with [68Ga]Ga-PSMA-11 PET/CT2022
Should Contemporary Western Guidelines Based on Studies Conducted in the 2000s Be Adopted for the Prostate-Specific Antigen Screening Policy for Asian Men in the 2020s?
Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and TrendsClinical Drug Investigation
Detection of Circulating Glial Cells Enables Non-Invasive Diagnosis of Glial Malignancies
Is docetaxel-free interval a predictive factor for castration-resistant prostate cancer?Actas Urológicas Españolas (English Edition)2022
US Population Reference Values for Health-Related Quality of Life Questionnaires Based on Demographics of Patients with Prostate CancerAdvances in Therapy
¿Es el intervalo libre de docetaxel un factor predictivo para el cáncer de próstata resistente a la castración?Actas Urológicas Españolas2022
Primary Tumor Staging and Detection of Common Sites of Distant Metastatic Disease2022
A Healthy Lifestyle in Men at Increased Genetic Risk for Prostate CancerEuropean Urology2022
Pathological Roles of Reactive Oxygen Species in Male ReproductionAdvances in Experimental Medicine and Biology2022
99mTc-PSMA SPECT in Prostate CancerClinical and Translational Imaging
Accurate Prostate Cancer Detection based on Circulating Tumor Cell Profiling
Association of the USPSTF Grade D Recommendation Against Prostate-Specific Antigen Screening With Prostate Cancer-Specific Mortality.JAMA Network Open2022
Lutetium Lu 177 Vipivotide Tetraxetan: First Approval.Molecular Diagnosis and Therapy2022
Office-Based, Single-Sided, Low-Field MRI-Guided Prostate BiopsyCureus2022
Lower fracture rates in patients treated with Radium-223, abiraterone or enzalutamide, when given concurrently with bone health agents: A real world analysisClinical Genitourinary Cancer2022
A narrative review of biparametric MRI (bpMRI) implementation on screening, detection, and the overall accuracy for prostate cancer.Therapeutic Advances in Urology2022
Racial/Ethnic Differences in Health-Related Quality of Life Among Gay and Bisexual Prostate Cancer Survivors.Frontiers in Oncology2022
Evaluation of maintenance of the common androgen deprivation therapy with the new antiandrogen therapy in patients with castration-resistant prostate cancer: a systematic review.International Urology and Nephrology2022
Focal prostate cancer therapy in the era of multiparametric MRI: a review of options and outcomes.Prostate Cancer and Prostatic Diseases2022
Real-World Prostate-Specific Antigen Response and Treatment Adherence of Apalutamide in Patients with Non-Metastatic Castration-Resistant Prostate Cancer.Urology2022
PSA Testing in Men Receiving Testosterone Therapy with History of Prostate Cancer: A Matched Analysis of a Large Multi-Institutional Research Network.Urology2022
Development of a novel castration-resistant orthotopic prostate cancer model in New Zealand White rabbit.Prostate2022
Assessing the impact of decision aid use on post prostatectomy patient reported outcomes.Urology2022
Development of a Sexual Quality of Life Questionnaire for Men-Who-Have-Sex-With-Men With Prostate Cancer.Sexual Medicine2022
Re: NCCN Prostate Cancer Guidelines Version 1.2022 - September 10, 2021.European Urology2021
Promoting informed prostate cancer screening decision-making for African American men in a community-based setting.Cancer Causes and Control2022
Biomarkers in Urinary Tract and Male Genital System Carcinomas2022
Population-based survival for cancer patients in Saudi Arabia for the years 2005-2009.Scientific Reports2022
Examination of prostate-specific antigen (PSA) screening in military and civilian men: analysis of the 2018 behavioral risk factor surveillance system.Cancer Causes and Control2022
Metastatic Prostate Adenocarcinoma: A Rare Presentation.Cureus2022
Racial Differences in Prostate Cancer Characteristics and Cancer-Specific Mortality: An Overview.World Journal of Men?s Health2022
El índice nutricional pronóstico como factor pronóstico independiente para la respuesta al tratamiento, la supervivencia y la elección del fármaco en el cáncer de próstata metastásico resistente a la castración tratado con acetato de abiraterona o enzalutamidaActas Urológicas Españolas2021
Targeted Radionuclide Therapy and Immunotherapy of Metastatic Prostate Cancer2022
Improved survival with post-diagnostic metformin and statin use in a racially diverse cohort of US Veterans with advanced prostate cancerProstate Cancer and Prostatic Diseases2021
Estimating the Financial Impact of Gene Therapy*
Nutraceuticals and Wellness2020
The Handbook of Wellness Medicine2020
Genetic Contributions to Prostate Cancer Disparities in Men of West African DescentFrontiers in Oncology2021
A Jaw-Dropping DiagnosisJournal of Hospital Medicine2020
Virtue Chapter2020
ADC mapping with 12 b values: an improved technique for image quality in diffusion prostate MRI
Comparative study between monoexponential and biexponential diffusion weighted imaging sequences in multiparametric prostate magnetic resonance imagingEinstein (Sao Paulo, Brazil)2019
Transition from normal to cancerous cell by precancerous niche (PCN) induced chronic cell-matrix stress4open2019